newsfilter
← Latest News
GlobeNewswire·

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutical company focused on rare diseases, today announced financial results for